Insulin antagonistic effects of epinephrine and glucagon in the dog.

The effect of glucagon and/or epinephrine on the response to physiologic insulin infusion was evaluated in dogs. Insulin alone produced a transient fall (50%) in glucose output, a threefold rise in glucose clearance, and a decline in plasma glucose, which then stabilized (40--45 mg/dl) afer 1 h. Glucagon infusion prevented the fall in glucose output, but had no effect on insulin-induced elevations in glucose clearance. The fall in plasma glucose was delayed (20 min), but late hypoglycemia was unaltered. Epinephrine infusion blocked the fall in glucose output as well as the insulin-induced rise in glucose clearance and uptake. Thus, while epinephrine and glucagon were equally effective in preventing the fall in glucose output induced by insulin, epinephrine was more effective in preventing insulin-induced hypoglycemia by virtue of its direct inhibitory action on insulin-stimulated glucose utilization. Simultaneous addition of glucagon and epinephrine increased glucose output twofold, suppressed glucose clearance, and caused a 15--30 mg/dl increase in plasma glucose despite ongoing hyperinsulinemia. Our data thus indicate that synergistic hormone interactions may play a role in the counterregulation of insulin hypoglycemia.

[1]  P. Cryer,et al.  Blood Glucose Regulates the Effects of Insulin and Counterregulatory Hormones on Glucose Production In Vivo , 1979, Diabetes.

[2]  M S Harris,et al.  Relationship between the plasma glucose level and glucose uptake in the conscious dog. , 1978, Metabolism: clinical and experimental.

[3]  P. Cryer,et al.  The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. , 1976, The Journal of clinical investigation.

[4]  R. Sherwin,et al.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. , 1976, The New England journal of medicine.

[5]  M. Vranic,et al.  The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs. , 1976, The Journal of clinical investigation.

[6]  P. Cryer,et al.  Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. , 1974, The Journal of clinical endocrinology and metabolism.

[7]  M. Vranic,et al.  Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. , 1974, Metabolism: clinical and experimental.

[8]  M Berman,et al.  A model of the kinetics of insulin in man. , 1974, The Journal of clinical investigation.

[9]  N. Christensen Plasma Norepinephrine and Epinephrine in Untreated Diabetics, During Fasting and After Insulin Administration , 1974, Diabetes.

[10]  J. Gerich,et al.  Characterization of the glucagon response to hypoglycemia in man. , 1974, The Journal of clinical endocrinology and metabolism.

[11]  G. Hetényi,et al.  Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. , 1971, Metabolism: clinical and experimental.

[12]  J. Sokal,et al.  Antagonism Between the Effects of Insulin and Glucagon on the Isolated Liver , 1969, Diabetes.

[13]  C. Park,et al.  Control of gluconeogenesis in liver. II. Effects of glucagon, catecholamines, and adenosine 3',5'-monophosphate on gluconeogenesis in the perfused rat liver. , 1968, The Journal of biological chemistry.

[14]  S. Berson,et al.  Separation of Antibody-Bound and Unbound Peptide Hormones Labelled with Iodine-131 by Talcum Powder and Precipitated Silica , 1966, Nature.

[15]  E. Ramey,et al.  Epinephrine action on glucose uptake by rat diaphragm; effect of ionic composition. , 1960, The American journal of physiology.

[16]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[17]  R. Steele,et al.  Further studies on the mechanism of action of insulin. , 1959, Metabolism: clinical and experimental.